Immitra Bio

Scalable In-vivo Gene Editing Platform

Immitra Bio was founded in 2024, is headquartered in Schlieren, Switzerland, lists 1–10 employees, and has $3.0M in recorded funding across 1 round.

Headquarters
Schlieren, Zurich
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$3.0M
Last Round
$3.0M Pre-SeedJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Immitra Bio develops a platform for scalable, one-time curative in-vivo gene editing therapies using mutation-agnostic gene editing technology and digital target identification. Its approach avoids complex ex-vivo cell manipulation, patient conditioning, stem cell transplantation, and personalized therapies. Its digital target discovery platform and editing mode enable off-the-shelf drug formulations designed to treat patients within a disease regardless of the underlying mutation, addressing scalability, access, and commercial viability limitations.

Summary

Immitra Bio is a Biotech company based in Schlieren, Switzerland, founded in 2024. It lists 1–10 employees. It has raised $3.0M in total across 1 round, most recently a $3.0M Pre-Seed round in Jul 2026. Investors include BackBone Ventures and OCCIDENT.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedJul 2026
$3.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Immitra Bio on Indexed.vc
<a href="https://indexed.vc/companies/immitra-bio"><img src="https://indexed.vc/api/badge/company/immitra-bio" alt="Immitra Bio on Indexed.vc" width="260" height="76" /></a>